Multiple myeloma-associated VTE risk prediction. A talk report from the 10th ICTHIC
During the 10th ICTHIC, prof Kristen Sanfilippo (Assistant Professor at the Washington University School of Medicine in...
ICTHIC 2021
VTE in Palliative Care Patients: What do we know? A talk report from the 10th ICTHC
During the 10th ICTHIC, Professor Simon Noble (Cardiff University, UK) talked about the management of VTE in patients...
Inpatient thromboprophylaxis in cancer patients: what is the evidence? A talk report from the 10th ICTHIC
During the 10th ICTHIC, Prof. Jeffrey Zwicker (Harvard Medical School, MA, USA) gave an overview of the evidence of the...
Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia and preliminary data from the MATTER study: A talk report from the 10th ICTHIC conference
During the 10th ICTHIC, Dr. Avi Leader (hematologist at Rabin Medical Center in Petah Tikva, Israel) talked about...
Incidental VTE: to treat or not to treat? – A debate from the 10th ICTHIC
During the 10th ICTHIC, Prof. Marcello di Nisio (University of Chieti, Italy) and Prof. Marc Carrier (Ottawa Hospital...
Differences in thromboprophylaxis between hospitalized patients with solid or hematological malignancies: A talk with Prof. Páramo
José Antonio Páramo is a Professor of Hematology at the University Clinic of Navarra, University of Navarra,...
Risk assessment models for venous thromboembolism in ambulatory patients with cancer: A talk with Prof. Gerotziafas
Prof Gerotziafas is a specialist in thrombosis and hemostasis with a particular interest in cancer-associated...
Cancer-associated thrombosis in the pediatric setting: A chat with Prof. Gili Kenet
Prof. Gili Kenet is a Pediatric Hematologist, Professor and Chair of the Haematology Department at the Sackler Medical...
Risk prediction for cancer‐associated thrombosis: A talk with Prof. Pabinger
Professor Pabinger is a hematologist at the University of Vienna, where she studies cancer and thrombosis. During the...